These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. The bioavailability of digoxin. Lancet; 1972 Aug; 2(7772):311-2. PubMed ID: 4115037 [No Abstract] [Full Text] [Related]
45. Pharmacokinetics and bioavailability of digoxin capsules, solution and tablets after single and multiple doses. Lloyd BL; Greenblatt DJ; Allen MD; Harmatz JS; Smith TW Am J Cardiol; 1978 Jul; 42(1):129-36. PubMed ID: 677028 [No Abstract] [Full Text] [Related]
46. Proceedings: Influence of formulation on absorption and clinical effect of digoxin. Shaw TR; Howard MR; Hamer J Br Heart J; 1974 Apr; 36(4):400. PubMed ID: 4841478 [No Abstract] [Full Text] [Related]
47. Dissolution of digoxin tablets. Ng K; McCredie RM Med J Aust; 1974 May; 1(18):698-700. PubMed ID: 4851406 [No Abstract] [Full Text] [Related]
48. The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps. Johnson BF; Smith G; French J Br J Clin Pharmacol; 1977 Apr; 4(2):209-11. PubMed ID: 861135 [TBL] [Abstract][Full Text] [Related]
50. [Biological availability of digoxin and beta-acetyldigoxin after single-dose administration (author's transl)]. Clasen R; Kemmeter H; Gilfrich HJ Dtsch Med Wochenschr; 1979 Apr; 104(15):543-6. PubMed ID: 436626 [TBL] [Abstract][Full Text] [Related]
51. Influence of dispersion method on dissolution rate and bioavailability of digoxin from triturations and compressed tablets II. Shah N; Pytelewski R; Eisen H; Jarowski CI J Pharm Sci; 1974 Mar; 63(3):339-44. PubMed ID: 4820360 [No Abstract] [Full Text] [Related]
52. [Clinical study of the biological availability of lanatoside C and digoxin in long-term tests]. Bodem G; Ochs H; Hahn E; Dengler HJ Schweiz Med Wochenschr; 1977 May; 107(19):658-66. PubMed ID: 867012 [TBL] [Abstract][Full Text] [Related]
53. Comparative study of the absorption, plasma levels, and urinary excretion of the "new" and the "old" Lanoxin. Falch D; Teien A; Bjerkelund CJ Br Med J; 1973 Mar; 1(5855):695-7. PubMed ID: 4694690 [TBL] [Abstract][Full Text] [Related]
54. Serum levels and renal excretion of digoxin in the elderly. A comparison between three different preparations. Iisalo E; Ruikka I Acta Med Scand; 1974; 196(1-2):59-63. PubMed ID: 4422001 [No Abstract] [Full Text] [Related]
56. Tablet disintegration: possible link with biological availability of digoxin. Manninen V; Melin J; Reissel P Lancet; 1972 Feb; 1(7748):490-1. PubMed ID: 4109834 [No Abstract] [Full Text] [Related]
57. [The biological availability of several digoxin preparations used in the Netherlands]. Dunning AJ; Buurke EJ; Roos JC; Paalman AC; van Rooy HH Ned Tijdschr Geneeskd; 1973 Dec; 117(48):1809-16. PubMed ID: 4788673 [No Abstract] [Full Text] [Related]
58. Altered absorption of digoxin in patients given propantheline and metoclopramide. Manninen V; Apajalahti A; Melin J; Karesoja M Lancet; 1973 Feb; 1(7800):398-400. PubMed ID: 4119707 [No Abstract] [Full Text] [Related]
59. Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin. Wagner JG; Ayres JW J Pharmacokinet Biopharm; 1977 Oct; 5(5):533-57. PubMed ID: 925886 [No Abstract] [Full Text] [Related]
60. [Metabolism and pharmacokinetics of lanatosides in man]. Rietbrock N; Abshagen U Dtsch Med Wochenschr; 1973 Jan; 98(3):117-22. PubMed ID: 4684137 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]